DelveInsight Business Research, LLP: Obesity Market to Showcase Robust Growth at a CAGR of 23% by 2032
The obesity market is expected to grow significantly owing to an increase in upcoming novel treatment options, increasing market size due to increasing prevalence, and increasing global healthcare
Shruti Thakur Innovent Biologics Saxenda Novo Nordisk Filgrastim Biosimilar Xenical Hoffmann Nusirt Biopharma
Source: finanznachrichten.de